We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLYA.WS
5801
DELISTED
SOAR Technology Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FLYA.WS
0
JYAC
5802
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$9K ﹤0.01%
900
TSPQ.WS
5803
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
0
CLAS.WS
5804
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
0
ABOS icon
5805
Acumen Pharmaceuticals
ABOS
$181M
$8K ﹤0.01%
1,622
-16,427
-91% -$61.7K
BLCO icon
5806
Bausch + Lomb
BLCO
$5.99B
$8K ﹤0.01%
+496
New +$8.04K
CSAN icon
5807
Cosan
CSAN
$2.52B
$8K ﹤0.01%
569
EMLC icon
5808
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.78B
$8K ﹤0.01%
317
FBIO icon
5809
Fortress Biotech
FBIO
$91.4M
$8K ﹤0.01%
674
-2,294
-77% -$34K
FTFT icon
5810
Future FinTech Group
FTFT
$1.51M
$8K ﹤0.01%
24
-88
-79% -$39.1K
OUNZ icon
5811
VanEck Merk Gold Trust
OUNZ
$2.73B
$8K ﹤0.01%
447
SGML icon
5812
Sigma Lithium
SGML
$1.32B
$8K ﹤0.01%
505
-14,740
-97% -$236K
SHFS icon
5813
SHF Holdings
SHFS
$1.14M
$8K ﹤0.01%
+38
New +$7.63K
SLS icon
5814
SELLAS Life Sciences
SLS
$2.31B
$8K ﹤0.01%
+3,550
New +$10.4K
SMG icon
5815
CALL
ScottsMiracle-Gro
SMG
$3.62B
$8K ﹤0.01%
+100
New +$9.88K
SMG icon
5816
PUT
ScottsMiracle-Gro
SMG
$3.62B
$8K ﹤0.01%
+100
New +$9.88K
TUSK icon
5817
Mammoth Energy Services
TUSK
$158M
$8K ﹤0.01%
3,575
-327
-8% -$733
USIG icon
5818
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$8K ﹤0.01%
144
-12,409
-99% -$646K
WDH
5819
Waterdrop
WDH
$359M
$8K ﹤0.01%
6,000
WEAV icon
5820
Weave Communications
WEAV
$401M
$8K ﹤0.01%
2,695
+456
+20% +$2.19K
XLO icon
5821
Xilio Therapeutics
XLO
$59.5M
$8K ﹤0.01%
195
-151
-44% -$7.99K
XNET
5822
Xunlei
XNET
$316M
$8K ﹤0.01%
5,153
-20,286
-80% -$28.8K
BNT
5823
Brookfield Wealth Solutions
BNT
$12.2B
$8K ﹤0.01%
251
-4,702
-95% -$156K
CALT
5824
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$8K ﹤0.01%
453
+21
+5% +$366
IRAAW
5825
DELISTED
Iris Acquisition Corp Warrant
IRAAW
0

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.